Amiodarone Hydrochloride Injection, Solution
Product Images NDC 51662-1205

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Amiodarone Hydrochloride (NDC 51662-1205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (1000060 0143 9875 01 Amiodarone Single Dose Vial)

Label for Amiodarone Hydrochloride Injection, 50 mg/mL (150 mg/3 mL) intravenous solution in a 3 mL single dose vial. The label instructs dilution before use and notes usual dosage instructions in the package insert. The product is manufactured by Hikma Farmacêutica (Portugal) and distributed by West-Ward Pharmaceutical Corp., Eatontown, NJ, USA.*

FDA Label Image

5166212052 Label

Label for Amiodarone Hydrochloride Injection 150 mg/3 mL (50 mg/mL) vial. The label shows the NDC number 51662-1205-2, lot code, and expiration date of 2021-06-01. It includes storage instructions, notes that the injection is for intravenous use only, requires dilution before use, and must be protected from light and excessive heat. Distributed by HF Acquisition Co., LLC in Mukilteo, WA.*

FDA Label Image

5166212053 Rfid Label

A small white pharmaceutical label featuring a data matrix barcode and alphanumeric text. The label includes product identification numbers and states 'See manufacturer's package insert.' It notes distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275, and has 'RX ONLY' printed vertically on the right edge.*

FDA Label Image

5166212053 Label

Label for AMIODARONE HYDROCHLORIDE injection, solution, 150 mg/3 mL (50 mg/mL) vial, box of 25. The label includes the NDC 51662-1205-3, lot number, and expiration date 2021-06-01. It is distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The label states it is for intravenous use only and must be diluted before use.*

FDA Label Image

Adverse (Adverse)

Table presenting study events from controlled (n=814) and open-label studies (n=1022) totaling 1836 participants. Events include fever, cardiovascular issues such as bradycardia, congestive heart failure, heart arrest, hypotension, ventricular tachycardia, and digestive system events like abnormal liver function tests and nausea, with counts and percentages for each study type and total.*

FDA Label Image

Clinical (Clinical Pharma)

Table comparing the effects of intravenous and oral formulations on cardiac parameters including SCL, QRS, QTc, AH, HV, ERP RA, ERP RV, and ERP AVN, using symbols to indicate direction or no change for each parameter.*

FDA Label Image

Dosage 1 (Dosage Tabel 1)

Table presenting dosing instructions for AMIODARONE HYDROCHLORIDE injection. It details loading infusions with a first rapid dose of 150 mg over 10 minutes followed by a slower dose of 360 mg over 6 hours, including volumes and concentrations for dilution in D5W. Maintenance infusion guidance describes 540 mg over 18 hours and rate adjustments.*

FDA Label Image

Dosage 2 (Dosage Tabel 2)

A data table displaying the physical compatibility of Amiodarone Hydrochloride injection solution in 5% Dextrose in Water (D5W) at concentrations of 1 to 6 mg/mL. The table compares container types, PVC and Polyolefin/Glass, noting amiodarone loss of less than 10% at 2 hours with PVC and no amiodarone loss at 24 hours with Polyolefin or Glass at room temperature.*

FDA Label Image

Dosage 3 (Dosage Tabel 3)

A data table listing various drugs tested with Amiodarone Hydrochloride in a D5W vehicle, showing Amiodarone concentrations and comments. Drugs include Aminophylline, Cefamandole Nafate, Cefazolin Sodium, Mezlocillin Sodium, Heparin Sodium, and Sodium Bicarbonate. The table notes precipitation occurs in all combinations except for Heparin Sodium, where concentration data is absent.*

FDA Label Image

Dosage 4 (Dosage Tabel 4)

A table showing the initial daily oral dose of Amiodarone based on the duration of Amiodarone infusion. It lists doses for durations of less than 1 week, 1 to 3 weeks, and more than 3 weeks, with decreasing dose amounts as the infusion duration increases.*

FDA Label Image

Serialized Label (Serialized 51662 1205 1 Amiodarone 2ml Vial)

AMIODARONE HYDROCHLORIDE 50 mg/mL injection solution vial with a blue cap. The label displays the product name and strength, with a red background section indicating 150 mg in 3 mL. The vial is distributed by HF Acquisition Co. LLC, DBA HealthFirst. The label includes a QR code and text for manufacturer information and prescription-only designation.*

FDA Label Image

Structure (Structure)

Chemical structure of amiodarone hydrochloride, showing its atomic composition and bonding arrangement including iodine, oxygen, nitrogen atoms and alkyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.